The treatment is shorter and more convenient, but it will not suit every man with prostate cancer.
Justin Stebbing, Professor of Biomedical Sciences, Anglia Ruskin University
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 16
- Comments 0